Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: Majestic Books, Hounslow, Regno Unito
EUR 33,78
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Royal Society of Chemistry RSC, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: Books Puddle, New York, NY, U.S.A.
Condizione: New.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: Biblios, Frankfurt am main, HESSE, Germania
EUR 32,67
Quantità: 4 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: SMASS Sellers, IRVING, TX, U.S.A.
Condizione: New. Brand New, Softcover edition. This item may ship from the US or our Overseas warehouse depending on your location and stock availability.
Da: UK BOOKS STORE, London, LONDO, Regno Unito
EUR 56,57
Quantità: 17 disponibili
Aggiungi al carrelloCondizione: New. Brand New ! Fast Delivery "International Edition " and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 4-6 Working days .and we do have flat rate for up to 2LB. Extra shipping charges will be requested This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: Basi6 International, Irving, TX, U.S.A.
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: SMASS Sellers, IRVING, TX, U.S.A.
Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: SMASS Sellers, IRVING, TX, U.S.A.
Condizione: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 219,22
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Royal Society of Chemistry, GB, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: Rarewaves USA, OSWEGO, IL, U.S.A.
EUR 221,59
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. Orphan drugs are designated drug substances that are intended to treat rare or 'orphan' diseases. More than 7000 rare diseases are known that collectively affect some 6-7% of the developed world's population; however, individually, any single, rare disease may only affect a handful of people making them commercially unattractive for the biopharmaceutical industry to target.Ground breaking legislation, starting with the Orphan Drug Act that was passed in the US in 1983 to provide financial incentives for companies to develop orphan drugs, has sparked ever increasing interest from biopharmaceutical companies to tackle rare diseases. These developments have made rare diseases, and the orphan drugs that treat them, sufficiently attractive to pharmaceutical development and many pharmaceutical companies now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research.Written by a combination of academic and industry experts working in the field, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat.Providing an up-to-date monograph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs and will appeal to medicinal and pharmaceutical chemists, biochemists and anyone working within the fields of rare disease research and drug development or pharmaceuticals in industry or academia.
HRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 224,28
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: PBShop.store UK, Fairford, GLOS, Regno Unito
EUR 247,11
Quantità: 15 disponibili
Aggiungi al carrelloHRD. Condizione: New. New Book. Shipped from UK. Established seller since 2000.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: GreatBookPricesUK, Woodford Green, Regno Unito
EUR 244,21
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 254,26
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: Royal Society of Chemistry, GB, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: Rarewaves USA United, OSWEGO, IL, U.S.A.
EUR 224,29
Quantità: Più di 20 disponibili
Aggiungi al carrelloHardback. Condizione: New. Orphan drugs are designated drug substances that are intended to treat rare or 'orphan' diseases. More than 7000 rare diseases are known that collectively affect some 6-7% of the developed world's population; however, individually, any single, rare disease may only affect a handful of people making them commercially unattractive for the biopharmaceutical industry to target.Ground breaking legislation, starting with the Orphan Drug Act that was passed in the US in 1983 to provide financial incentives for companies to develop orphan drugs, has sparked ever increasing interest from biopharmaceutical companies to tackle rare diseases. These developments have made rare diseases, and the orphan drugs that treat them, sufficiently attractive to pharmaceutical development and many pharmaceutical companies now have research units dedicated to this area of research. It is therefore timely to review the area of orphan drugs and some of the basic science, drug discovery and regulatory factors that underpin this important, and growing, area of biomedical research.Written by a combination of academic and industry experts working in the field, this text brings together expert authors in the regulatory, drug development, genetics, biochemistry, patient advocacy group, medicinal chemistry and commercial domains to create a unique and timely reference for all biomedical researchers interested in finding out more about orphan drugs and the rare diseases they treat.Providing an up-to-date monograph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs and will appeal to medicinal and pharmaceutical chemists, biochemists and anyone working within the fields of rare disease research and drug development or pharmaceuticals in industry or academia.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 255,17
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: GreatBookPrices, Columbia, MD, U.S.A.
EUR 292,06
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: As New. Unread book in perfect condition.
Lingua: Inglese
Editore: ROYAL SOCIETY OF CHEMISTRY, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: moluna, Greven, Germania
EUR 239,03
Quantità: Più di 20 disponibili
Aggiungi al carrelloGebunden. Condizione: New. This book provides an up-to-date monograph on the drug discovery and regulatory elements of therapuetics used to treat rare or orphan diseases.Über den AutorrnrnDavid C. Pryde is a medicinal chemist based at Pfizer Global Research .
Da: UK BOOKS STORE, London, LONDO, Regno Unito
EUR 310,27
Quantità: 5 disponibili
Aggiungi al carrelloHardcover. Condizione: New. Brand New! Fast Delivery This is an International Edition and ship within 24-48 hours. Deliver by FedEx and Dhl, & Aramex, UPS, & USPS and we do accept APO and PO BOX Addresses. Order can be delivered worldwide within 7-12 days and we do have flat rate for up to 2LB. Extra shipping charges will be requested if the Book weight is more than 5 LB. This Item May be shipped from India, United states & United Kingdom. Depending on your location and availability.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2014
ISBN 10: 1849738068 ISBN 13: 9781849738064
Da: Revaluation Books, Exeter, Regno Unito
EUR 320,32
Quantità: 2 disponibili
Aggiungi al carrelloHardcover. Condizione: Brand New. 1st edition. 463 pages. 9.75x6.75x1.50 inches. In Stock.
EUR 294,80
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware - Orphan drugs are designated drug substances that are intended to treat rare or 'orphan' diseases. More than 7000 rare diseases are known that collectively affect some 6-7% of the developed world's population, but individually, any single rare disease may only affect a handful of people making them unattractive for the biopharmaceutical industry to target. Providing an up-to-date mongraph, this book covers the basic science, drug discovery and regulatory elements behind orphan drugs.